Cardiovascular and respiratory effects of incremental doses of dopamine and phenylephrine in the management of isoflurane-induced hypotension in cats with hypertrophic cardiomyopathy

American Journal of Veterinary Research

Volumn 73, Issue 6, 2012, Pages 908-916

  Wiese, Ashley J ^a,c   Barter, Linda S ^a   Ilkiw, Jan E ^a   Kittleson, Mark D ^b   Pypendop, Bruno H ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DOPAMINE; ISOFLURANE; PHENYLEPHRINE; TROPONIN I;

ACID BASE BALANCE; ARTERIAL PRESSURE; ARTICLE; CAT; FEMALE; HEART INDEX; HYPERTROPHIC CARDIOMYOPATHY; HYPOTENSION; LACTATE BLOOD LEVEL; MALE; NONHUMAN; OXYGEN CONSUMPTION; TISSUE OXYGENATION; VASCULAR RESISTANCE;

ANIMALS; BLOOD PRESSURE; CARDIOMYOPATHY, HYPERTROPHIC; CAT DISEASES; CATS; CROSS-OVER STUDIES; DOPAMINE; DOSE-RESPONSE RELATIONSHIP, DRUG; HYPOTENSION; ISOFLURANE; OXYGEN; OXYGEN CONSUMPTION; PHENYLEPHRINE; PROSPECTIVE STUDIES; TROPONIN I; VASCULAR RESISTANCE;

ANIMALIA;

EID: 84861540987     PISSN: 00029645     EISSN: None     Source Type: Journal    
DOI: 10.2460/ajvr.73.6.908     Document Type: Article

References (42)

1. Riesen SC, Kovacevic A, Lombard CW, et al. Prevalence of heart disease in symptomatic cats: an overview from 1998 to 2005. Schweiz Arch Tierheilkd 2007;149:65-71.
2. Paige CF, Abbott JA, Elvinger F, et al. Prevalence of cardiomyopathy in apparently healthy cats. J Am Vet Med Assoc 2009;234:1398-1403.
3. Kittleson MD. Hypertrophic cardiomyopathy. In: Kittleson MD, Kienle RD, eds. Small animal cardiovascular medicine. St Louis: Mosby, 1998;248-259.
4. Fox PR, Liu SK, Maron BJ. Echocardiographic assessment of spontaneously occurring feline hypertrophic cardiomyopathy: an animal model of human disease. Circulation 1995;92:2645-2651.
5. Ferasin L, Sturgess CP, Canon MJ, et al. Feline idiopathic cardiomyopathy: a retrospective study of 106 cats (1994-2001). J Feline Med Surg 2003;5:151-159.
6. Fox PR. Hypertrophic cardiomyopathy. Clinical and pathologic correlates. J Vet Cardiol 2003;5:39-45.
7. Connolly DJ, Cannata J, Boswood A, et al. Cardiac troponin I in cats with hypertrophic cardiomyopathy. J Feline Med Surg 2003;5:209-216.
8. Herndon WE, Kittleson MD, Sanderson K, et al. Cardiac troponin I in feline hypertrophic cardiomyopathy. J Vet Intern Med 2002;16:558-564.
9. Sleeper MM, Clifford CA, Laster LL. Cardiac troponin I in the normal dog and cat. J Vet Intern Med 2001;15:501-503.
10. Maron BJ. Hypertrophic cardiomyopathy: a systematic review. JAMA 2002;287:1308-1320.
11. Haering JM, Comunale ME, Parker RA, et al. Cardiac risk of noncardiac surgery in patients with asymmetric septal hypertrophy. Anesthesiology 1996;85:254-259.
12. Poliac LC, Barron ME, Maron BJ. Hypertrophic cardiomyopathy. Anesthesiology 2006;104:183-192.
13. Harley ID, Jones EF, Liu G, et al. Orthotopic liver transplantation in two patients with hypertrophic obstructive cardiomyopathy. Br J Anaesth 1996;77:675-677.
14. Robertson A. Intraoperative management of liver transplantation in patients with hypertrophic cardiomyopathy: a review. Trans Proc 2010;42:1721-1723.
15. Hreybe H, Zahid M, Sonel A, et al. Noncardiac surgery and the risk of death and other cardiovascular events in patients with hypertrophic cardiomyopathy. Clin Cardiol 2006;29:65-68.
16. Hodgson DS, Dunlop CI, Chapman PL, et al. Cardiopulmonary effects of anesthesia induced and maintained with isoflurane in cats. Am J Vet Res 1998;59:182-185.
17. Vivien B, Hanouz JL, Gueugniaud PY, et al. Myocardial effects of halothane and isoflurane in hamsters with hypertrophic cardiomyopathy. Anesthesiology 1997;87:1406-1416.
18. Pascoe PJ, Ilkiw JE, Pypendop BH. Effects of increasing infusion rates of dopamine, dobutamine, epinephrine, and phenylephrine in healthy anesthetized cats. Am J Vet Res 2006;67:1491-1499.
19. Lamont LA, Bulmer BJ, Sisson DD, et al. Doppler echocardiographic effects of medetomidine on dynamic left ventricular outflow tract obstruction in cats. J Am Vet Med Assoc 2002;221:1276-1281.
20. Darovic GO. Pulmonary artery pressure monitoring. In: Darovic GO, ed. Hemodynamic monitoring: invasive and noninvasive clinical application. 3rd ed. Philadelphia: WB Saunders Co, 2002;191-243.
21. Lumb AB. Oxygen. In: Lumb AB, ed. Nunn's applied respiratory physiology. 5th ed. Oxford, England: Butterworth-Heinemann, 2000;249-305.
22. Vincent JL. Arterial, central venous, and pulmonary artery catheters. In: Parrillo JE, Dellinger FP, eds. Critical care medicine- principles of diagnosis and management of the adult. 3rd ed. Philadelphia: Mosby Elsevier, 2008;53-83.
23. Cummins B, Cummins P. Cardiac specific troponin-I release in canine experimental myocardial infarction: development of a sensitive and specific enzyme-linked immunoassay. J Mol Cell Cardiol 1987;19:999-1010.
24. Adams HR. Adrenergic agonists and antagonists. In: Riviere JE, Papich MG, eds. Veterinary pharmacology and therapeutics. 9th ed. Ames, Iowa: Iowa State Press, 2009;125-143.
25. Carlos Sampedrano C, Chetboul V, Gouni V, et al. Systolic and diastolic myocardial dysfunction in cats with hypertrophic cardiomyopathy or systemic hypertension. J Vet Intern Med 2006;20:1106-1115.
26. Wess G, Sarkar R, Hartmann K. Assessment of left ventricular systolic function by strain imaging echocardiography in various stages of feline hypertrophic cardiomyopathy. J Vet Intern Med 2010;24:1375-1382.
27. Overgaard CB, Dzavik V. Inotropes and vasopressors: review of physiology and clinical use in cardiovascular disease. Circulation 2008;118:1047-1056.
28. Cilli F, Alibhai HIK, Armitage-Chan E, et al. Incidence of elevation of cardiac troponin I prior to and following routine general anaesthesia in dogs. Vet Anaesth Analg 2010;37:409-416.
29. Sellgren J, Biber B, Henriksson BA, et al. The effects of propofol, methohexitone and isoflurane on the baroreceptor reflex in the cat. Acta Anaesthesiol Scand 1992;36:784-790.
30. Gobel FL, Nordstrom LA, Nelson RR, et al. The rate-pressure product as an index of myocardial oxygen consumption during exercise in patients with angina pectoris. Circulation 1978;57:549-556.
31. Holmberg S, Varnauskas E. Coronary circulation during pacing induced tachycardia. Acta Med Scand 1971;190:481-490.
32. Vatner SF, Higgins CB, Franklin D, et al. Role of tachycardia in mediating the coronary hemodynamic response to severe exercise. J Appl Physiol 1972;32:380-385.
33. Côté E, Jaeger R. Ventricular tachyarrhythmias in 106 cats: associated structural cardiac disorders. J Vet Intern Med 2008;22:1444-1446.
34. Boyden PA, Tilley LP, Albala A, et al. Mechanisms for atrial arrhythmias associated with cardiomyopathy: a study of feline hearts with primary myocardial disease. Circulation 1984;69:1036-1047.
35. Sprung CL, Jacobs LJ, Caralis PV, et al. Ventricular arrhythmias during Swan-Ganz catheterization of the critically ill. Chest 1981;79:413-415.
36. Lejeune P, Leeman M, Deloof T, et al. Pulmonary hemodynamic response to dopamine and dobutamine in hyperoxic and in hypoxic dogs. Anesthesiology 1987;66:49-54.
37. Seri I. Systemic and pulmonary effects of vasopressors and inotropes in the neonate. Biol Neonate 2006;89:340-342.
38. Harrison DC, Pirages S, Robison SC, et al. The pulmonary and systemic circulatory response to dopamine infusion. Br J Pharmacol 1969;37:618-626.
39. Waaler BA. Effect of dopamine on the isolated perfused lung lobes of the dog. Br J Pharmacol Chemother 1961;16:195-202.
40. Graham R, Skoog C, Macedo W, et al. Dopamine, dobutamine, and phentolamine effects on pulmonary vascular mechanics. J Appl Physiol 1983;54:1277-1283.
41. Hyman AL, Kadowitz PJ. Evidence for existence of postjunctional α1- and α2-adrenoceptors in cat pulmonary vascular bed. Am J Physiol 1985;249:H891-H898.
42. Kaye AD, Hoover JM, Baber SR, et al. Effects of norepinephrine on α-subtype receptors in the feline pulmonary vascular bed. Crit Care Med 2004;32:2300-2303.